FCGR3A 蛋白
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| FCGR3A Protein (AA 24-190) (His tag) | 小鼠 | Bacteria |
|
|
|
| FCGR3A Protein (AA 1-208) (His tag) | 人 | Eukaryota |
|
|
|
| FCGR3A Protein (AA 26-108) (His tag) | 人 | Bacteria |
|
|
|
| FCGR3A Protein (AA 17-208) (His tag) | 人 | Bacteria |
|
|
|
| FCGR3A Protein (Fc Tag) | Cynomolgus | HEK-293 Cells |
|
|
|
| FCGR3A Protein (His tag) | 人 | 大肠杆菌(E. Coli) |
|
|
|
| FCGR3A Protein (His tag) | 人 | 大肠杆菌(E. Coli) |
|
|
|
| FCGR3A Protein (AA 17-208, V176F) (His tag) | 人 | 人细胞 |
|
|
|
| FCGR3A Protein (His tag) | 人 | Mammalian Cells |
|
|
|
| FCGR3A Protein (His tag) | 人 | 人细胞 |
|
|
|
| FCGR3A Protein (His tag) | 人 | 人细胞 |
|
|
- 宿主
- Cynomolgus
- 宿主
- HEK-293 Cells
- 蛋白类型
- Recombinant
- 纯度
- The purity of the protein is greater than 95 % as determined by SDS-PAGE and Coomassie blue staining.
- SDS (SDS-PAGE: 所列应用)
- WB (Western Blotting: 所列应用)
- Imm (Immunogen: 所列应用)
- ELISA (ELISA: 所列应用)
- 宿主
- 人
- 宿主
- 大肠杆菌(E. Coli)
- 蛋白类型
- Recombinant
- SDS (SDS-PAGE: 所列应用)
- WB (Western Blotting: 所列应用)
- Imm (Immunogen: 所列应用)
- ELISA (ELISA: 所列应用)
- 宿主
- 人
- 宿主
- 大肠杆菌(E. Coli)
- 蛋白类型
- Recombinant
- SDS (SDS-PAGE: 所列应用)
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- MS (Mass Spectrometry: 所列应用)
- 宿主
- 人
- 宿主
- 人细胞
- 蛋白类型
- Recombinant
- 纯度
- Greater than 95 % as determined by reducing SDS-PAGE.
- SDS (SDS-PAGE: 所列应用)
- WB (Western Blotting: 所列应用)
- Imm (Immunogen: 所列应用)
- ELISA (ELISA: 所列应用)
- 宿主
- 人
- 宿主
- Mammalian Cells
- 蛋白类型
- Recombinant
- 宿主
- 人
- 宿主
- 人细胞
- 蛋白类型
- Recombinant
- 纯度
- Greater than 95 % as determined by reducing SDS-PAGE.
- 宿主
- 人
- 宿主
- 人细胞
- 蛋白类型
- Recombinant
- 纯度
- Greater than 95 % as determined by reducing SDS-PAGE.
Latest Publications for our FCGR3A 蛋白
: "Effects of terminal galactose residues in mannose α1-6 arm of Fc-glycan on the effector functions of therapeutic monoclonal antibodies." in: mAbs, Vol. 11, Issue 5, pp. 826-836, (2020) (PubMed).
: "Control of therapeutic IgG antibodies galactosylation during cultivation process and its impact on IgG1/FcγR interaction and ADCC activity." in: Biologicals : journal of the International Association of Biological Standardization, Vol. 58, pp. 16-21, (2019) (PubMed).
: "Identification of anti-CD16a single domain antibodies and their application in bispecific antibodies." in: Cancer biology & therapy, pp. 1-9, (2019) (PubMed).
: "Structural and functional characterization of MBS301, an afucosylated bispecific anti-HER2 antibody." in: mAbs, Vol. 10, Issue 6, pp. 864-875, (2019) (PubMed).
: "Charge variant analysis of proposed biosimilar to Trastuzumab." in: Biologicals : journal of the International Association of Biological Standardization, Vol. 46, pp. 46-56, (2017) (PubMed).
: "Fc gamma receptor glycosylation modulates the binding of IgG glycoforms: a requirement for stable antibody interactions." in: Journal of proteome research, Vol. 13, Issue 12, pp. 5471-85, (2014) (PubMed).
: "Discovery and characterization of a peptide motif that specifically recognizes a non-native conformation of human IgG induced by acidic pH conditions." in: The Journal of biological chemistry, Vol. 284, Issue 15, pp. 9986-93, (2009) (PubMed).
Aliases for FCGR3A 蛋白
Fc fragment of IgG receptor IIIa (FCGR3A) 蛋白Fc fragment of IgG receptor IIIa (Fcgr3a) 蛋白
CD16 蛋白
CD16A 蛋白
FCG3 蛋白
FCGR3 蛋白
Fcgr4 蛋白
FCGRIII 蛋白
FCR-10 蛋白
FCRIII 蛋白
FCRIIIA 蛋白
IGFR3 蛋白